MedTrace Logo

Influence of Enteral Microbiome on Mortality of Patients With Cardiogenic Shock

NCT06006754 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-08-24

No results posted yet for this study

Summary

Cardiogenic shock is associated with a high mortality. The microbiome is a double-edged sword which can convey protective and detrimental cardiovascular effects. The significance of the enteral micobiome on cardiovascular mortality of patients with cardiogenic shock is still not known.

This study aims to provide a deeper understanding of the role of the enteral microbiome and microbiome dependent metabolites in mortality and disease progression of patients with cardiogenic shock.

Conditions

  • Cardiogenic Shock
  • Microbial Colonization
  • Out-Of-Hospital Cardiac Arrest
  • Acute Heart Failure
  • Acute Myocardial Infarction

Interventions

OTHER

Observational study

No intervention: observational study

Sponsors & Collaborators

  • University Hospital, Essen

    lead OTHER

Principal Investigators

  • Christos Rammos, Prof. Dr. · University Clinic Essen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-30
Primary Completion
2024-08-15
Completion
2025-02-15

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06006754 on ClinicalTrials.gov